FDA Clears Technology That Distinguishes Between Bacterial and Viral Infections
The FDA has granted 510(k) clearance for technology to distinguish between bacterial and viral infections in both children and adults.
Read MorePosted by Chris Wolski | Sep 27, 2021 | Infectious Diseases, POC Instruments |
The FDA has granted 510(k) clearance for technology to distinguish between bacterial and viral infections in both children and adults.
Read MorePosted by Toni Mitchell | Sep 23, 2021 | Covid 19, POC Rapid Assays |
BD, a medical technology company, has been selected by the state of Washington to provide options for COVID-19 testing and screening in K-12 schools.
Read MorePosted by Chris Wolski | Sep 20, 2021 | POC Instruments, POC Rapid Assays, POC Reagents & Test Kits |
The Tech Guide from the September 2021 issue of Clinical Lab Products includes point-of-care assays and analyzers from 17 suppliers.
Read MorePosted by Toni Mitchell | Sep 13, 2021 | Diabetes & Metabolic Diseases |
Low-cost screen printed carbon sensors — used to rapidly detect bacteria commonly found in wounds — could pave the way for a real-time medical device.
Read MorePosted by Chris Wolski | Sep 9, 2021 | Sepsis |
Ke Du, PhD, is developing a microfluidic device to improve detection of drug resistant bacteria in blood, one of the most common pathogens causing sepsis.
Read More